Zeo ScientifiX (ZEOX) Debt Ratio (2016 - 2024)
Zeo ScientifiX (ZEOX) posted quarterly Debt Ratio of 0.44 for Q4 2024, up 455.48% year-over-year from 0.08 in Q4 2023, and up 285.94% quarter-over-quarter from 0.11 in Q2 2024.
Zeo ScientifiX (ZEOX) Debt Ratio (2016 - 2024) Analysis & Trends
Zeo ScientifiX's Debt Ratio history runs 8 years deep, the most recent figure standing at 0.44 for Q4 2024.
- In Q4 2024, Debt Ratio rose 455.48% year-over-year to 0.44; the TTM figure through Oct 2024 stood at 0.44 (up 455.48% YoY), while the FY2024 annual figure was 0.44, up 455.48% from the prior year.
- Debt Ratio for Q4 2024 stood at 0.44, up from 0.11 in the prior quarter.
- The five-year high for Debt Ratio was 0.44 in Q4 2024, with the low at 0.05 in Q3 2022.
- The 5-year median for Debt Ratio is 0.14 (2020), against an average of 0.16.
- The sharpest annual moves came in 2020 and 2024: Debt Ratio plunged 92.46% in 2020, then jumped 455.48% in 2024.
- Zeo ScientifiX's Debt Ratio stood at 0.14 in 2020, then soared by 76.1% to 0.25 in 2021, then plunged by 48.63% to 0.13 in 2022, then sank by 37.17% to 0.08 in 2023, then surged by 455.48% to 0.44 in 2024.
- Business Quant data shows ZEOX's Debt Ratio at 0.44 in Q4 2024, 0.11 in Q2 2024, and 0.09 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 0.44 |
| Apr 30, 2024 | 0.11 |
| Jan 31, 2024 | 0.09 |
| Oct 31, 2023 | 0.08 |
| Jul 31, 2023 | 0.19 |
| Apr 30, 2023 | 0.16 |
| Jan 31, 2023 | 0.05 |
| Oct 31, 2022 | 0.13 |
| Jul 31, 2022 | 0.05 |
| Apr 30, 2022 | 0.06 |
| Jan 31, 2022 | 0.20 |
| Oct 31, 2021 | 0.25 |
| Jul 31, 2021 | 0.08 |
| Apr 30, 2021 | 0.11 |
| Jan 31, 2021 | 0.17 |
| Oct 31, 2020 | 0.14 |
| Jul 31, 2020 | 0.19 |
| Apr 30, 2020 | 0.28 |
| Jan 31, 2020 | 0.31 |
| Oct 31, 2019 | 0.57 |